[5]—of a progressive toxic role of PABPN1 nuclear aggregates leading to a loss of function—would explain why OPMD is a late onset muscular dystrophy affecting a selected set of muscles which are characterized by their low PABPN1 expression levels. This evidence concerns the gene PABPN1 and oculopharyngeal muscular dystrophy.